Details of the Drug Combinations | DrugMAP

General Information of This Drug (ID: DMCJY35)

Drug Name

MIN-101 DMCJY35

Synonyms

Roluperidone

Indication

Disease Entry	ICD 11	Status	REF
Schizophrenia	6A20	Phase 3	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
MIN-101 + Olanzapine	DCG6G7J	Olanzapine	Negative Symptoms in Schizophrenia	[2]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT03397134) Study to Evaluate Efficacy and Safety of Roluperidone (MIN-101) in Adult Patients With Negative Symptoms of Schizophrenia. U.S. National Institutes of Health.
2	ClinicalTrials.gov (NCT06107803) A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine in Adult Subjects With Moderate to Severe Negative Symptoms of Schizophrenia